As the article states, Katz Group Canada has signed a definitive agreement to sell its banner pharmacy business, Drug Trading, and its franchise pharmacy business, Medicine Shoppe Canada, to McKesson for about CAD $920 million in cash. Katz Group stated that the sale to McKesson will enable the former to focus on its corporate-owned Rexall and Rexall/Pharma Plus store network. So as new CEO Frank Scorpiniti, who officially succeeded Andy Giancamilli on Feb. 2, settles into his new role and focuses on the core banner, industry members pretty much can bet on seeing even more changes down the road. In fact, Katz Group has announced that its Rexall division has acquired Dell Pharmacies, an 18-store chain operating in southern Ontario with approximately $70 million in annual sales. The Dell stores will be integrated into the Rexall network.